ARCHIVES

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

This article is from The Cancer Letter archive.

Vol. 18 No. 25 | June 19, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

Senate Markup Of Labor-HSS-Education Money Bill Delayed Until After Congress August Recess

August 4, 1989

AACR Receives Record Number of Abstracts

January 27, 1989

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000